515120 创新药ETF
已收盘 11-22 14:59:59
资讯
新帖
简况
【ETF动向】11月18日广发中证香港创新药ETF(QDII)基金跌2.04%,份额增加7700万份
证券之星 · 11-19
【ETF动向】11月18日广发中证香港创新药ETF(QDII)基金跌2.04%,份额增加7700万份
【ETF动向】11月14日广发中证香港创新药ETF(QDII)基金跌1.6%,份额增加1.94亿份
证券之星 · 11-15
【ETF动向】11月14日广发中证香港创新药ETF(QDII)基金跌1.6%,份额增加1.94亿份
【ETF动向】11月12日广发中证香港创新药ETF(QDII)基金跌0.65%,份额增加2.52亿份
证券之星 · 11-13
【ETF动向】11月12日广发中证香港创新药ETF(QDII)基金跌0.65%,份额增加2.52亿份
【ETF动向】10月30日广发中证香港创新药ETF(QDII)基金跌3.45%,份额增加1.18亿份
证券之星 · 10-31
【ETF动向】10月30日广发中证香港创新药ETF(QDII)基金跌3.45%,份额增加1.18亿份
广发基金刘杰旗下广发中证香港创新药ETF(QDII)三季报最新持仓,重仓药明生物
证券之星 · 10-25
广发基金刘杰旗下广发中证香港创新药ETF(QDII)三季报最新持仓,重仓药明生物
【ETF动向】10月10日广发中证香港创新药ETF(QDII)基金涨2.77%,份额减少1.48亿份
证券之星 · 10-11
【ETF动向】10月10日广发中证香港创新药ETF(QDII)基金涨2.77%,份额减少1.48亿份
【ETF动向】10月8日广发中证香港创新药ETF(QDII)基金涨2.77%,份额增加4.57亿份
证券之星 · 10-09
【ETF动向】10月8日广发中证香港创新药ETF(QDII)基金涨2.77%,份额增加4.57亿份
【ETF动向】9月30日广发中证香港创新药ETF(QDII)基金涨9.78%,份额增加1.9亿份
证券之星 · 10-01
【ETF动向】9月30日广发中证香港创新药ETF(QDII)基金涨9.78%,份额增加1.9亿份
【ETF动向】9月23日广发中证香港创新药ETF(QDII)基金跌0.15%,份额增加1.14亿份
证券之星 · 09-24
【ETF动向】9月23日广发中证香港创新药ETF(QDII)基金跌0.15%,份额增加1.14亿份
ETF午盘|各ETF跌多涨少 创新药ETF跌逾2.3%
市场透视 · 09-20
ETF午盘|各ETF跌多涨少 创新药ETF跌逾2.3%
【ETF动向】9月13日广发中证香港创新药ETF(QDII)基金涨1.99%,份额减少1.76亿份
证券之星 · 09-14
【ETF动向】9月13日广发中证香港创新药ETF(QDII)基金涨1.99%,份额减少1.76亿份
【ETF动向】9月11日广发中证香港创新药ETF(QDII)基金涨2.19%,份额减少1.08亿份
证券之星 · 09-12
【ETF动向】9月11日广发中证香港创新药ETF(QDII)基金涨2.19%,份额减少1.08亿份
【ETF动向】9月2日广发中证香港创新药ETF(QDII)基金跌1.99%,份额增加9850万份
证券之星 · 09-03
【ETF动向】9月2日广发中证香港创新药ETF(QDII)基金跌1.99%,份额增加9850万份
【ETF动向】8月29日广发中证香港创新药ETF(QDII)基金涨1.09%,份额减少2.02亿份
证券之星 · 08-30
【ETF动向】8月29日广发中证香港创新药ETF(QDII)基金涨1.09%,份额减少2.02亿份
创新药龙头业绩超预期刺激板块情绪向好!创新药ETF(159992)溢价交易频现,特宝生物涨13.07%。
每日经济新闻 · 08-22
创新药龙头业绩超预期刺激板块情绪向好!创新药ETF(159992)溢价交易频现,特宝生物涨13.07%。
创新药ETF(159992)盘中溢价,人福医药涨超2%,机构:看好创新药板块后续行情丨ETF观察
21世纪经济报道 · 08-21
创新药ETF(159992)盘中溢价,人福医药涨超2%,机构:看好创新药板块后续行情丨ETF观察
【ETF动向】8月19日广发中证香港创新药ETF(QDII)基金跌0.15%,份额减少2.14亿份
证券之星 · 08-20
【ETF动向】8月19日广发中证香港创新药ETF(QDII)基金跌0.15%,份额减少2.14亿份
9月即将闪“药“国际舞台!创新药ETF(159992)频现溢价交易,连续5个交易日获得资金净流入,浙江医药涨超5.32%
每日经济新闻 · 08-07
9月即将闪“药“国际舞台!创新药ETF(159992)频现溢价交易,连续5个交易日获得资金净流入,浙江医药涨超5.32%
关键政策持续落地催化!创新药ETF(159992)连续4个交易日获得资金大幅净流入,迪哲医药-U涨超5%
每日经济新闻 · 08-06
关键政策持续落地催化!创新药ETF(159992)连续4个交易日获得资金大幅净流入,迪哲医药-U涨超5%
【ETF动向】8月5日广发中证香港创新药ETF(QDII)基金跌1.12%,份额增加2.53亿份
证券之星 · 08-06
【ETF动向】8月5日广发中证香港创新药ETF(QDII)基金跌1.12%,份额增加2.53亿份
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"515120","market":"SH","secType":"STK","nameCN":"创新药ETF","latestPrice":0.531,"timestamp":1732258799000,"preClose":0.555,"halted":0,"volume":250657900,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.024,"latestTime":"11-22 14:59:59","open":0.555,"high":0.555,"low":0.531,"amount":136000000,"amplitude":0.0432,"askPrice":0.532,"askSize":2532,"bidPrice":0.531,"bidSize":42221,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":0.555,"symbolType":"fund","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":0.611,"lowLimit":0.5,"ibTradeSell":false,"ibTradeBuySell":true,"pbRate":0,"committee":0.5201,"marketValue":0,"floatMarketCap":0,"changeRate":-0.0432,"turnoverRate":0,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-11-25。","discountRate":"0.00%","netWorth":"0.000"},"requestUrl":"/m/hq/s/515120/wiki","defaultTab":"wiki","newsList":[{"id":"2484801509","title":"【ETF动向】11月18日广发中证香港创新药ETF(QDII)基金跌2.04%,份额增加7700万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2484801509","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484801509?lang=zh_cn&edition=full","pubTime":"2024-11-19 06:30","pubTimestamp":1731969048,"startTime":"0","endTime":"0","summary":"证券之星消息,11月18日,广发中证香港创新药ETF(QDII)基金(513120)跌2.04%,成交额12.79亿元。当日份额增加了7700万份,最新份额为99.13亿份,近20个交易日份额增加11.54亿份。当日资金净流出1.01亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为70.91亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-18.42%,近一个月超额回报为-2.67%,管理人为广发基金公司,基金经理为刘杰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111900004695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2483535136","title":"【ETF动向】11月14日广发中证香港创新药ETF(QDII)基金跌1.6%,份额增加1.94亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2483535136","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483535136?lang=zh_cn&edition=full","pubTime":"2024-11-15 06:30","pubTimestamp":1731623447,"startTime":"0","endTime":"0","summary":"证券之星消息,11月14日,广发中证香港创新药ETF(QDII)基金(513120)跌1.6%,成交额11.76亿元。当日份额增加了1.94亿份,最新份额为98.27亿份,近20个交易日份额增加10.9亿份。当日资金净流入570.96万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为72.18亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-16.97%,近一个月超额回报为-0.73%,管理人为广发基金公司,基金经理为刘杰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500004359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2483232069","title":"【ETF动向】11月12日广发中证香港创新药ETF(QDII)基金跌0.65%,份额增加2.52亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2483232069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483232069?lang=zh_cn&edition=full","pubTime":"2024-11-13 06:30","pubTimestamp":1731450649,"startTime":"0","endTime":"0","summary":"证券之星消息,11月12日,广发中证香港创新药ETF(QDII)基金(513120)跌0.65%,成交额28.93亿元。当日份额增加了2.52亿份,最新份额为95.17亿份,近20个交易日份额增加7.8亿份。当日资金净流入1.8亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为73.07亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-17.6%,近一个月超额回报为-0.26%,管理人为广发基金公司,基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111300004624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2479606447","title":"【ETF动向】10月30日广发中证香港创新药ETF(QDII)基金跌3.45%,份额增加1.18亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2479606447","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479606447?lang=zh_cn&edition=full","pubTime":"2024-10-31 06:30","pubTimestamp":1730327449,"startTime":"0","endTime":"0","summary":"证券之星消息,10月30日,广发中证香港创新药ETF(QDII)基金(513120)跌3.45%,成交额17.32亿元。当日份额增加了1.18亿份,最新份额为90.06亿份,近20个交易日份额增加7.28亿份。当日资金净流出1.05亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为68.31亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-17.11%,近一个月超额回报为-0.99%,管理人为广发基金公司,基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100008409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2478958256","title":"广发基金刘杰旗下广发中证香港创新药ETF(QDII)三季报最新持仓,重仓药明生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2478958256","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478958256?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:52","pubTimestamp":1729871559,"startTime":"0","endTime":"0","summary":"证券之星消息,10月25日广发基金旗下刘杰管理的广发中证香港创新药交易型开放式指数基金(QDII)公布三季报,近1年净值增长率-1.93%。与上一季度相比,该基金前十大重仓股新增药明康德,金斯瑞生物科技;并对药明生物增仓298.85万股,为该基金第一大重仓股;再鼎医药,三生制药等退出前十大重仓股;详细数据如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500050733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0417516902.SGD","LU0307460666.USD","LU0456827905.SGD","LU1242518857.USD","LU0052750758.USD","BK1141","LU0326950275.SGD","LU0348825331.USD","BK1576","LU0516423091.SGD","LU0039217434.USD","LU1720050803.USD","SG9999002562.SGD","LU0359201612.USD","LU0516422952.EUR","LU0417516738.SGD","LU0823426480.USD","BK1610","LU0327786744.USD","LU0181495838.USD","LU1794554557.SGD","LU0823426308.USD","LU0979878070.USD","IE00B0JY6N72.USD","LU0348735423.USD","LU0819121731.USD","LU0516422440.USD","LU0043850808.USD","LU1880383366.USD","BK1521","LU0572944931.SGD","LU0708995583.HKD","LU1242518931.SGD","LU0516422366.SGD","LU2039709279.SGD","LU0359202008.SGD","LU1688375341.USD","LU0588546209.SGD","LU0856984785.SGD","SG9999002463.SGD","BK1589","515120","02269","LU0051755006.USD","LU0140636845.USD","LU0456846285.SGD","LU0516423174.USD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2474052705","title":"【ETF动向】10月10日广发中证香港创新药ETF(QDII)基金涨2.77%,份额减少1.48亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2474052705","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474052705?lang=zh_cn&edition=full","pubTime":"2024-10-11 06:30","pubTimestamp":1728599447,"startTime":"0","endTime":"0","summary":"证券之星消息,10月10日,广发中证香港创新药ETF(QDII)基金(513120)涨2.77%,成交额37.44亿元。当日份额减少了1.48亿份,最新份额为87.78亿份,近20个交易日份额增加5.16亿份。当日资金净流出2155.41万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为71.84亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-18.51%,近一个月超额回报为-3.45%,管理人为广发基金公司,基金经理为刘杰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101100003651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2474128067","title":"【ETF动向】10月8日广发中证香港创新药ETF(QDII)基金涨2.77%,份额增加4.57亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2474128067","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474128067?lang=zh_cn&edition=full","pubTime":"2024-10-09 06:30","pubTimestamp":1728426652,"startTime":"0","endTime":"0","summary":"证券之星消息,10月8日,广发中证香港创新药ETF(QDII)基金(513120)涨2.77%,成交额46.86亿元。当日份额增加了4.57亿份,最新份额为89.27亿份,近20个交易日份额增加7.73亿份。当日资金净流入6.32亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为74.44亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-14.15%,近一个月超额回报为3.81%,管理人为广发基金公司,基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100900002550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2472363770","title":"【ETF动向】9月30日广发中证香港创新药ETF(QDII)基金涨9.78%,份额增加1.9亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2472363770","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472363770?lang=zh_cn&edition=full","pubTime":"2024-10-01 06:30","pubTimestamp":1727735452,"startTime":"0","endTime":"0","summary":"证券之星消息,9月30日,广发中证香港创新药ETF(QDII)基金(513120)涨9.78%,成交额48.27亿元。当日份额增加了1.9亿份,最新份额为84.71亿份,近20个交易日份额增加1.48亿份。当日资金净流入5.08亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为68.12亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-16.91%,近一个月超额回报为-0.38%,管理人为广发基金公司,基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100100008854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2469745331","title":"【ETF动向】9月23日广发中证香港创新药ETF(QDII)基金跌0.15%,份额增加1.14亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2469745331","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469745331?lang=zh_cn&edition=full","pubTime":"2024-09-24 06:30","pubTimestamp":1727130658,"startTime":"0","endTime":"0","summary":"证券之星消息,9月23日,广发中证香港创新药ETF(QDII)基金(513120)跌0.15%,成交额13.56亿元。当日份额增加了1.14亿份,最新份额为81.17亿份,近20个交易日份额减少4.26亿份。当日资金净流出7056.36万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为54.86亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-13.9%,近一个月超额回报为0.16%,管理人为广发基金公司,基金经理为刘杰。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092400004089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2468666648","title":"ETF午盘|各ETF跌多涨少 创新药ETF跌逾2.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468666648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468666648?lang=zh_cn&edition=full","pubTime":"2024-09-20 11:35","pubTimestamp":1726803330,"startTime":"0","endTime":"0","summary":"ETF方面,各ETF跌多涨少,黄金股ETF、房地产ETF、地产ETF等涨幅居前,分别涨2.24%、涨2.04%、涨1.83%;创新药ETF、国防军工ETF、半导体设备ETF等跌幅居前,分别跌2.3%、跌2.15%、跌2.13%;华宝添益ETF、银华日利ETF、短融ETF等成交额居前,分别成交51.3亿元、成交41.04亿元、成交38.39亿元。分品种来看,今日主题ETF表现优于行业ETF及跨境ETF,其中黄金股ETF基金涨2.49%、计算机ETF南方涨1.99%、教育ETF涨1.69%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409201135149570c2a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409201135149570c2a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["561980","515120"],"gpt_icon":0},{"id":"2467038635","title":"【ETF动向】9月13日广发中证香港创新药ETF(QDII)基金涨1.99%,份额减少1.76亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2467038635","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467038635?lang=zh_cn&edition=full","pubTime":"2024-09-14 06:31","pubTimestamp":1726266663,"startTime":"0","endTime":"0","summary":"证券之星消息,9月13日,广发中证香港创新药ETF(QDII)基金(513120)涨1.99%,成交额12.04亿元。当日份额减少了1.76亿份,最新份额为79.98亿份,近20个交易日份额减少7.58亿份。当日资金净流出634.7万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为53.4亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-13.37%,近一个月超额回报为1.06%,管理人为广发基金公司,基金经理为刘杰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091400005060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2466906261","title":"【ETF动向】9月11日广发中证香港创新药ETF(QDII)基金涨2.19%,份额减少1.08亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2466906261","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466906261?lang=zh_cn&edition=full","pubTime":"2024-09-12 06:30","pubTimestamp":1726093855,"startTime":"0","endTime":"0","summary":"证券之星消息,9月11日,广发中证香港创新药ETF(QDII)基金(513120)涨2.19%,成交额11.48亿元。当日份额减少了1.08亿份,最新份额为81.75亿份,近20个交易日份额减少5.86亿份。当日资金净流入7910.92万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为53.6亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-12.83%,近一个月超额回报为1.76%,管理人为广发基金公司,基金经理为刘杰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091200004561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2464098860","title":"【ETF动向】9月2日广发中证香港创新药ETF(QDII)基金跌1.99%,份额增加9850万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2464098860","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464098860?lang=zh_cn&edition=full","pubTime":"2024-09-03 06:30","pubTimestamp":1725316258,"startTime":"0","endTime":"0","summary":"证券之星消息,9月2日,广发中证香港创新药ETF(QDII)基金(513120)跌1.99%,成交额7.13亿元。当日份额增加了9850万份,最新份额为82.53亿份,近20个交易日份额减少5.52亿份。当日资金净流出1029.8万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为52.86亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-13.22%,近一个月超额回报为1.09%,管理人为广发基金公司,基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090300005011.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2463987212","title":"【ETF动向】8月29日广发中证香港创新药ETF(QDII)基金涨1.09%,份额减少2.02亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2463987212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463987212?lang=zh_cn&edition=full","pubTime":"2024-08-30 06:32","pubTimestamp":1724970728,"startTime":"0","endTime":"0","summary":"证券之星消息,8月29日,广发中证香港创新药ETF(QDII)基金(513120)涨1.09%,成交额10.44亿元。当日份额减少了2.02亿份,最新份额为83.23亿份,近20个交易日份额减少2.09亿份。当日资金净流出4856.81万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为54.22亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-13.18%,近一个月超额回报为1.42%,管理人为广发基金公司,基金经理为刘杰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083000007098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2461915338","title":"创新药龙头业绩超预期刺激板块情绪向好!创新药ETF(159992)溢价交易频现,特宝生物涨13.07%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2461915338","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461915338?lang=zh_cn&edition=full","pubTime":"2024-08-22 09:58","pubTimestamp":1724291886,"startTime":"0","endTime":"0","summary":"8月22日,创新药板块震荡走强。成分股中,特宝生物涨13.07%,恒瑞医药、海思科等均涨超2%。创新药ETF市场热度较高,过去一个月日均成交额2.13亿元,实时净申购达900万份。创新药ETF跟踪创新药指数,该指数布局创新药产业链龙头企业,既汇聚全球CXO龙头企业,又包含国内仿创药企龙头,有望同时受益于仿制药业务的修复和创新药业务的放量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822095815a1d58e63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822095815a1d58e63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600276","688278","159992","515120","BK0239"],"gpt_icon":0},{"id":"2461649558","title":"创新药ETF(159992)盘中溢价,人福医药涨超2%,机构:看好创新药板块后续行情丨ETF观察","url":"https://stock-news.laohu8.com/highlight/detail?id=2461649558","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461649558?lang=zh_cn&edition=full","pubTime":"2024-08-21 10:53","pubTimestamp":1724208780,"startTime":"0","endTime":"0","summary":"相关ETF方面,创新药ETF截至发稿下跌0.16%,成交额超5000万元;溢折率0.23%,盘中频现溢价交易。创新药ETF紧密跟踪中证创新药产业指数,该指数选取主营业务涉及创新药研发的上市公司作为待选样本,按照市值排序选取不超过50家最具代表性公司作为样本股,反映创新药产业上市公司的整体表现,为投资者提供新的投资标的。西南证券表示,看好创新药板块后续行情。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408211100219f402949&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408211100219f402949&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","600079","BK0028","BK0012","BK0185","159992","515120","BK0188","BK0096","BK0239"],"gpt_icon":0},{"id":"2460093334","title":"【ETF动向】8月19日广发中证香港创新药ETF(QDII)基金跌0.15%,份额减少2.14亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2460093334","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460093334?lang=zh_cn&edition=full","pubTime":"2024-08-20 06:30","pubTimestamp":1724106649,"startTime":"0","endTime":"0","summary":"证券之星消息,8月19日,广发中证香港创新药ETF(QDII)基金(513120)跌0.15%,成交额7.84亿元。当日份额减少了2.14亿份,最新份额为85.42亿份,近20个交易日份额增加4500万份。当日资金净流出1.7亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为56.14亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-13.77%,近一个月超额回报为0.68%,管理人为广发基金公司,基金经理为刘杰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082000004006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2457589298","title":"9月即将闪“药“国际舞台!创新药ETF(159992)频现溢价交易,连续5个交易日获得资金净流入,浙江医药涨超5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457589298","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457589298?lang=zh_cn&edition=full","pubTime":"2024-08-07 10:39","pubTimestamp":1722998359,"startTime":"0","endTime":"0","summary":"截至发稿,创新药指数低位上行,逼近翻红。浙江医药涨超5.32%,通化金马、科伦药业涨势占优。相关ETF方面,创新药ETF小幅调整,实时成交额超1亿元,交易活跃度高,过去5个交易日获得资金连续净流入,累计净流入金额达2.81亿元。创新药ETF跟踪创新药指数,该指数布局创新药产业链龙头企业,既汇聚全球CXO龙头企业,又包含国内仿创药企龙头,有望同时受益于仿制药业务的修复和创新药业务的放量。9月7日-9月10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080710394495846c4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080710394495846c4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","600216","159992","BK0028","BK0191","BK0239","515120"],"gpt_icon":0},{"id":"2457058150","title":"关键政策持续落地催化!创新药ETF(159992)连续4个交易日获得资金大幅净流入,迪哲医药-U涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457058150","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457058150?lang=zh_cn&edition=full","pubTime":"2024-08-06 10:07","pubTimestamp":1722910020,"startTime":"0","endTime":"0","summary":"相关ETF方面,创新药ETF现涨1.83%,开盘成交额超1.1亿元,交易活跃度高,过去5个交易日资金净流入达到1.5亿元,连续4个交易日获得资金净流入。创新药ETF跟踪创新药指数,该指数布局创新药产业链龙头企业,既汇聚全球CXO龙头企业,又包含国内仿创药企龙头,有望同时受益于仿制药业务的修复和创新药业务的放量。政策催化,叠加9月份的美联储降息和创新药全球学术会议,创新药板块有望迎来政策面、融资面、技术面的多重利好共振。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806100741af961702&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806100741af961702&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["515120","159992","688192","BK0239"],"gpt_icon":0},{"id":"2457829080","title":"【ETF动向】8月5日广发中证香港创新药ETF(QDII)基金跌1.12%,份额增加2.53亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2457829080","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457829080?lang=zh_cn&edition=full","pubTime":"2024-08-06 06:30","pubTimestamp":1722897047,"startTime":"0","endTime":"0","summary":"证券之星消息,8月5日,广发中证香港创新药ETF(QDII)基金(513120)跌1.12%,成交额17.21亿元。当日份额增加了2.53亿份,最新份额为88.05亿份,近20个交易日份额增加3亿份。当日资金净流入1.68亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为54.54亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-12.96%,近一个月超额回报为1.22%,管理人为广发基金公司,基金经理为刘杰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080600010144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0}],"profile":{"ret":0,"stockEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":-0.0345},{"period":"3month","weight":0.1853},{"period":"6month","weight":0.0663},{"period":"1year","weight":-0.1893},{"period":"ytd","weight":-0.138}],"compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0108},{"period":"3month","weight":0.1446},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.0671},{"period":"ytd","weight":0.0982}],"serverTime":1732347170960,"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创新药ETF(515120)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创新药ETF(515120)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创新药ETF,515120,创新药ETF股票,创新药ETF股票老虎,创新药ETF股票老虎国际,创新药ETF行情,创新药ETF股票行情,创新药ETF股价,创新药ETF股市,创新药ETF股票价格,创新药ETF股票交易,创新药ETF股票购买,创新药ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创新药ETF(515120)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创新药ETF(515120)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}